Generate a tailored SOP for Dr. Mark Pegram. Improve your application with a focused, well-structured draft.
Mark Pegram is the Suzy Yuan-Huey Hung Endowed Professor of Medical Oncology at Stanford University School of Medicine, where he serves as Associate Director of Clinical Research at the Stanford Comprehensive Cancer Institute. He is also the Associate Dean of Clinical Research Quality and the Medical Director of the Stanford Clinical Translational Research Unit. Dr. Pegram received his medical degree from the University of North Carolina at Chapel Hill and completed his internship and residency at the University of Texas Southwestern Medical Center. He then concluded his fellowship training in hematology/oncology at UCLA's David Geffen School of Medicine. Dr. Pegram's research centers on breast cancer, particularly in the study of the HER2 gene and the development of novel agents for treating HER2-positive metastatic breast cancer. He has published over 110 articles in the fields of medical oncology, hematology, and biosimilars. He is committed to educating healthcare professionals on the emerging impact of biosimilars in oncology, with a focus on breast cancer treatment.
Stanford University School of Medicine • Stanford, California
Serves as a member of the University Medical Line.
Stanford Clinical Translational Research Unit • Stanford, California
Oversees clinical trial operations in a unit specializing in first-in-human phase clinical trials.
Stanford University School of Medicine • Stanford, California
Responsible for ensuring quality in clinical research.
Stanford Comprehensive Cancer Institute • Stanford, California
Leads clinical research initiatives at the cancer institute.
The Computer Science department emphasizes research potential. GRE General is currently optional but recommended for some tracks.